mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
6e-05 |
mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
8e-05 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0002 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |